US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Terumo Neuro
Terumo Neuro Announces Publication of RESTORE Registry Results in the Journal of NeuroInterventional Surgery
November 17, 2026
From
Terumo Neuro
Via
GlobeNewswire
Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)
September 30, 2026
From
Terumo Neuro
Via
GlobeNewswire
Terumo Neuro Announces Two WISE Study Publications Reporting 0% New Bleeds or Rebleeds Through One Year Following WEB™ Treatment in Ruptured and Unruptured Aneurysm Cohorts
August 31, 2026
From
Terumo Neuro
Via
GlobeNewswire
Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial Aneurysms
May 14, 2026
From
Terumo Neuro
Via
GlobeNewswire
Terumo Neuro and Tulane University School of Medicine’s Dr. Kendrick Johnson Release Educational Video Highlighting the Importance of Stroke Awareness and Equitable Healthcare in Honor of World Stroke Day 2024
October 29, 2024
From
Terumo Neuro
Via
Business Wire
Terumo Neuro (Formerly MicroVention) to Host Grand Opening Ceremony for Newly Expanded Global Headquarters and Innovation Center in Aliso Viejo
October 01, 2024
From
Terumo Neuro
Via
Business Wire
MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic Growth
September 12, 2024
From
Terumo Neuro
Via
Business Wire